EUCTR2005-000614-12-IT进行中（未招募）不适用
Irbesartan in the treatment of Hypertensive Patients with Metabolic Syndrome.
BRISTOL-M.SQUIBB0 个研究点目标入组 540 人开始时间: 2006年3月23日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 540
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
1 期
Irbesartan in the treatment of Hypertensive Patients with Metabolic Syndrome.Irbesartan en el tratamiento del paciente hipertenso con síndrome metabólicoHypertension, nosEUCTR2005-000614-12-ESBristol Myers Squibb International Corporation540
进行中（未招募）
不适用
Irbesartan in the treatment of Hypertensive Patients with Metabolic Syndrome.Revised Protocol 2, incorporating Protocol Amendments 01 dated 09-Jan-06 & 02 dated 05-Oct-2006. And Protocol amendment 03 dated 24-Oct-2006 - Biomarkers Substudy.EUCTR2005-000614-12-DEBristol Myers Squibb International Corporation540
已完成
不适用
A study of irbesartan/amlodipine on hypertensive patientsHypertensionJPRN-UMIN000017785Kumamoto University20
招募中
4 期
Toyama antihypertensive therapy with Olmesartan in Post-Stroke patients (TOPS) studyHypertension, Post-strokeJPRN-UMIN000009790niversity of Toyama100
已完成
4 期
I SELECT - Irbesartan In Hypertensive Patients With Left Ventricular HypertrophyHypertensionNCT00362037Sanofi281